Venous Thromboembolism (VTE) Prevention Therapies

What are we measuring?
The percentage (%) of stroke patients receiving venous thromboembolism (VTE) prevention therapies during their hospital stay.
Why is this important?
Deep vein thrombosis (DVT) is the result of a clot that forms in one of the large veins in the body - most often in the legs or pelvis. It is important to deliver preventative therapies against DVTs to stroke patients with either medication or mechanical compression boots while they are in the hospital. Stroke patients have an increased risk of developing DVTs. Stroke patients need to continue preventative therapies when they are discharged from the hospital.
What is our most recent performance and trend?

back to top

Procoagulant Reversal Agent Initiation for ICH

What are we measuring?
The percentage (%) of patients with Intracerebral Hemorrhage who have an INR value >1.4 who were treated with a procoagulant reversal agent on hospital arrival.
Why is this important?
When patients who take medications to thin their blood have an Intracerebral hemorrhage it is very important to immediately reverse the affects of the blood thinner.   

back to top

Arrival to Skin Puncture (Median Time in minutes)

What are we measuring?
The median time from arrival at the hospital to the time of skin puncture to access the artery that will be used to for endovascular treatment.
Why is this important?
Ischemic stroke patients should begin endovascular treatment (e.g., groin puncture) within 6 hours of stroke symptom onset for best outcomes.

Source of BIDMC Data in the above graphs: American Heart Association's "Get with the Guidelines" data registry.

Source of comparison data: American Heart Association's "Get with the Guidelines" performance goal.

Last updated: March 2018